BCG Moreau Vaccine Safety Profile and NK Cells—Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined Immunodeficiency

Ewa Bernatowska,Małgorzta Skomska-Pawliszak,Beata Wolska-Kusnierz,Małgorzata Pac,Edyta Heropolitańska-Pliszka,Barbara Pietrucha,Katarzyna Bernat-Sitarz,Nel Dąbrowska Leonik,Nadia Bohynikova,Barbara Piątosa,Anna Lutyńska,Ewa Augustynowicz,Ewa Augustynowicz-Kopeć,Maria Korzeniewska Kosela,Maria Krasińska,Katarzyna Krzysztopa-Grzybowska,Anna Wieteska-Klimczak,Janusz Książyk,Teresa Jackowska,Mirjam van den Burg,Jacques J.M. van Dongen,Jean-Laurent Casanova,Capucine Picard,Bożena Mikołuć

BCG Moreau Vaccine Safety Profile and NK Cells—Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined Immunodeficiency

2019

Objectives The aim of the study was to estimate the rate of adverse reactions to live BCG Moreau vaccine, manufactured by Biomed in Poland, in severe combined immunodeficiency (SCID) patients.

Keywords:

Immunology
Biology
Vaccination
Virology
Retrospective cohort study
Disseminated BCG Infection
Severe combined immunodeficiency
Stem cell
Medical microbiology
Allergy
Haematopoiesis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations